While rare, ROS1 rearrangements have also been reported in gastric cancers, glioblastomas, cholangiocarcinomas, ovarian cancers, colorectal cancers, inflammatory myofibroblastic tumors, angiosarcomas, and epithelial hemangioendotheliomas8,11,12. This evidence concerns the gene ROS1 and inflammatory myofibroblastic tumor.